...
首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation
【24h】

Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation

机译:Peroxiredoxin I是ROS / p38 MAPK依赖型诱导型抗氧化剂,可调节NF-κB介导的iNOS诱导和小胶质细胞活化

获取原文
获取原文并翻译 | 示例

摘要

Reactive oxygen species (ROS) function as modulators of pro-inflammatory processes in microglia-associated neurodegenerative diseases.However, little is known about the involvement of specific antioxidants in regulating the microglial redox status. Here, we demonstrated that peroxiredoxin (Prx) I activity was induced by lipopolysaccharide (LPS), but not paraquat and hydrogen peroxide, through activation of the ROS/p38 MAPK signal pathway, and participated in alleviating the microglial activation and generation of nitric oxide (NO). Interestingly, a null mutation of Prx I accelerated NF-κB-mediated iNOS induction and subsequent NO secretion in LPS-stimulated microglia. Furthermore, F4/80 expression as microglial activation marker was notably up-regulated in primary cultures of microglia, hippocampal sections, and cerebral cortex of 15-month-old Prx I-/- mouse.Taken together, the results of our study indicated that Prx I is an antioxidant that is up-regulated in a ROS/p38 MAPK-dependent manner and governs the progression of neuroinflammation by suppressing microglial activation. In addition, Prx I deficiency increased the nuclear translocation of NF-κB mediated-iNOS induction as pro-inflammatory mediators.The findings of our work suggest possible strategies for developing novel therapies to treat inflammation-associated degenerative neurological diseases by targeting the induction of Prx I in microglial cells.
机译:活性氧(ROS)在小胶质细胞相关的神经退行性疾病中充当促炎过程的调节剂,但是,关于特定抗氧化剂参与调节小胶质细胞氧化还原状态的知之甚少。在这里,我们证明了过氧iredoxin(Prx)I的活性是通过激活ROS / p38 MAPK信号途径而被脂多糖(LPS)诱导的,而不是百草枯和过氧化氢诱导的,并且参与了减轻小胶质细胞活化和一氧化氮产生的过程没有)。有趣的是,Prx I的无效突变会加速LPS刺激的小胶质细胞中NF-κB介导的iNOS诱导和随后的NO分泌。此外,在15个月大的Prx I-/-小鼠的小胶质细胞,海马切片和大脑皮层的原代培养物中,F4 / 80作为小胶质细胞激活标志物的表达明显上调。 Prx I是一种抗氧化剂,以ROS / p38 MAPK依赖性方式上调,并通过抑制小胶质细胞活化来控制神经炎症的进展。此外,Prx I缺乏增加了NF-κB介导的iNOS诱导作为促炎性介质的核易位。我们的工作结果表明,通过靶向诱导Prx来开发治疗与炎症相关的退行性神经疾病的新疗法的可能策略我在小胶质细胞中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号